Cargando…
Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus
PURPOSE: The influenza B virus diverges into two antigenically distinct lineages: B/Yamagata and B/Victoria. Influenza B is the dominant circulating virus during some influenza seasons, and recent data demonstrated that influenza A and B infection similarly cause severe clinical symptoms in hospital...
Autores principales: | Lee, So-Young, Kang, Jung-Ok, Chang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369129/ https://www.ncbi.nlm.nih.gov/pubmed/30775351 http://dx.doi.org/10.7774/cevr.2019.8.1.54 |
Ejemplares similares
-
Control of mucosal virus infection by influenza nucleoprotein-specific CD8(+ )cytotoxic T lymphocytes
por: Mbawuike, Innocent N, et al.
Publicado: (2007) -
Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013) -
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells
Publicado: (1984) -
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes
Publicado: (1986) -
Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013)